Green Square Capital LLC decreased its stake in DaVita HealthCare Partners Inc. (NYSE:DVA) by 25.0% during the first quarter, Holdings Channel reports. The fund owned 3,000 shares of the company’s stock after selling 1,000 shares during the period. Green Square Capital LLC’s holdings in DaVita HealthCare Partners were worth $204,000 at the end of the most recent reporting period.

Other hedge funds have also recently modified their holdings of the company. First Financial Equity Corporation purchased a new stake in shares of DaVita HealthCare Partners during the first quarter valued at approximately $304,000. Oak Associates Ltd. OH boosted its stake in shares of DaVita HealthCare Partners by 225.3% in the first quarter. Oak Associates Ltd. OH now owns 152,910 shares of the company’s stock valued at $10,393,000 after buying an additional 105,910 shares during the last quarter. Kovitz Investment Group Partners LLC purchased a new stake in shares of DaVita HealthCare Partners during the first quarter valued at approximately $289,000. HighTower Advisors LLC boosted its stake in shares of DaVita HealthCare Partners by 71.0% in the first quarter. HighTower Advisors LLC now owns 55,730 shares of the company’s stock valued at $3,810,000 after buying an additional 23,137 shares during the last quarter. Finally, Park West Asset Management LLC boosted its stake in shares of DaVita HealthCare Partners by 88.8% in the first quarter. Park West Asset Management LLC now owns 1,856,516 shares of the company’s stock valued at $126,187,000 after buying an additional 873,064 shares during the last quarter. Hedge funds and other institutional investors own 82.46% of the company’s stock.

DaVita HealthCare Partners Inc. (DVA) traded down 0.22% during trading on Monday, reaching $64.75. The company’s stock had a trading volume of 258,138 shares. The company has a 50 day moving average price of $65.51 and a 200-day moving average price of $66.12. DaVita HealthCare Partners Inc. has a 52 week low of $54.50 and a 52 week high of $78.77. The company has a market capitalization of $12.60 billion, a PE ratio of 10.63 and a beta of 1.00.

DaVita HealthCare Partners (NYSE:DVA) last released its quarterly earnings results on Tuesday, May 2nd. The company reported $0.79 earnings per share for the quarter, missing the consensus estimate of $0.82 by $0.03. The company had revenue of $3.70 billion for the quarter, compared to analysts’ expectations of $3.69 billion. DaVita HealthCare Partners had a return on equity of 14.85% and a net margin of 8.28%. Equities research analysts anticipate that DaVita HealthCare Partners Inc. will post $3.54 earnings per share for the current year.

WARNING: “Green Square Capital LLC Has $204,000 Stake in DaVita HealthCare Partners Inc. (DVA)” was originally reported by Daily Political and is owned by of Daily Political. If you are viewing this piece on another site, it was copied illegally and republished in violation of US & international copyright & trademark law. The correct version of this piece can be accessed at https://www.dailypolitical.com/2017/06/26/green-square-capital-llc-has-204000-stake-in-davita-healthcare-partners-inc-dva.html.

Several brokerages recently commented on DVA. Jefferies Group LLC cut DaVita HealthCare Partners from a “buy” rating to a “hold” rating and boosted their price target for the stock from $64.89 to $70.00 in a research report on Monday. Goldman Sachs Group, Inc. (The) reissued a “sell” rating and set a $62.00 price objective on shares of DaVita HealthCare Partners in a research note on Thursday, May 25th. Zacks Investment Research lowered DaVita HealthCare Partners from a “buy” rating to a “hold” rating in a research note on Wednesday, April 19th. Finally, TheStreet raised DaVita HealthCare Partners from a “c+” rating to a “b-” rating in a research note on Monday, April 3rd. One investment analyst has rated the stock with a sell rating, eight have issued a hold rating and two have issued a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average price target of $69.50.

In other news, CEO Javier Rodriguez sold 1,294 shares of DaVita HealthCare Partners stock in a transaction on Monday, May 15th. The stock was sold at an average price of $66.21, for a total value of $85,675.74. Following the completion of the sale, the chief executive officer now owns 99,111 shares of the company’s stock, valued at $6,562,139.31. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Charles Berg sold 8,414 shares of DaVita HealthCare Partners stock in a transaction on Tuesday, May 9th. The shares were sold at an average price of $65.80, for a total value of $553,641.20. Following the completion of the sale, the director now directly owns 34,719 shares of the company’s stock, valued at approximately $2,284,510.20. The disclosure for this sale can be found here. In the last ninety days, insiders sold 22,702 shares of company stock valued at $1,495,492. Company insiders own 2.00% of the company’s stock.

DaVita HealthCare Partners Company Profile

DaVita Inc, formerly DaVita HealthCare Partners Inc, operates two divisions: DaVita Kidney Care (Kidney Care) and DaVita Medical Group (DMG). The Kidney Care division consists of its the United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support.

Want to see what other hedge funds are holding DVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DaVita HealthCare Partners Inc. (NYSE:DVA).

Institutional Ownership by Quarter for DaVita HealthCare Partners (NYSE:DVA)

Receive News & Ratings for DaVita HealthCare Partners Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DaVita HealthCare Partners Inc. and related companies with MarketBeat.com's FREE daily email newsletter.